gland pharma glp-1 capacity expansion capex Eli Lilly's $1 Billion India Bet GLP-1 Market Size to Hit

Our private Facebook forum has been created as a place for like-minded individuals to come together and encourage one another to reach their health and fitness goals

Tirzepatide is a GLP-1/GIP receptor agonist that has been studied in FDA-approved medications such as Mounjaro

Lower intake increases deficiency risk

NO DIGESTIVE ISSUES, OR NASTIES: Patches Avoid The Stomach And Digestive Issues

My latest for CNBC discusses how these new pills may not boost employer coverage.

A new Ohio bill aims to restore state employees access to GLP-1 weight-loss medications after the state dropped coverage in early 2025, citing high costs ->